Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Politics
Business
Trending on Bing
Senate passes foreign aid
Honors late husband on stage
Baldwin clash goes viral
Sued for harassment
'McCloud' actor dies at 95
Biden boosts overtime pay
Past audition experiences
Yale student killer sentenced
Clark's Nike 8-year contract
Judge drops border charges
Joins ‘Wednesday' S2 cast
Fort Wayne mayor sworn in
Cash's unreleased tracks
Bill to allow armed teachers
Reinstated after suspension
Jones' Dover absence
Ends bid for Congress
Accident on 'The Pickup' set
Announces more layoffs
$1B weapon aid for Ukraine
Abortion stance in Florida
Alaska plane crash
Stars charity challenge
X to launch TV app
Next product event: May 7
To star in novel adaptation
US charges 4 Iranians
Senate passes legislation
Calls for Netanyahu to resign
Bird flu virus found in milk
NBA Most Improved Player
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
precisionmedicineonline
4d
FDA Approves Genentech's Alecensa as Adjuvant Treatment for ALK-Positive Lung Cancer
With the FDA nod, Alecensa becomes the second molecularly targeted therapy to move into the adjuvant setting for non-small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results